Andrea Tedeschi

13PUBLICATIONS
47CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Molecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
The New Cardio-Oncology Frontier in Hematologic Cancers: Cardiovascular Toxicities of CAR-T Cells and Bispecific T-Cell Engagers.

|Aug 27, 2026
Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management.

|Jun 26, 2026
Cardiovascular Involvement in Erdheim-Chester Disease Presenting as Pericardial Tamponade: A Case Report and Multimodality Imaging Review.

|Jun 12, 2026
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune-Metabolic Myocardial Injury with Translational Cardio-Oncology.

|May 04, 2026
SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.

|Oct 29, 2025
Advancing Heart Failure Care: Breakthroughs and Emerging Strategies.

Andrea Tedeschi, Federico Barocelli, Luigi Gerra

Pageof 3

Frequent Collaborators

6 joint publications

Francesco Di Spigno

4 joint publications

Irma Bisceglia

4 joint publications

Nicola Maurea

4 joint publications

Matteo Palazzini